Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32801644)

  • 1. Synergistic Effect of Tangeretin and Atorvastatin for Colon Cancer Combination Therapy: Targeted Delivery of These Dual Drugs Using RGD Peptide Decorated Nanocarriers.
    Bao H; Zheng N; Li Z; Zhi Y
    Drug Des Devel Ther; 2020; 14():3057-3068. PubMed ID: 32801644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic chemopreventive effects of nobiletin and atorvastatin on colon carcinogenesis.
    Wu X; Song M; Qiu P; Rakariyatham K; Li F; Gao Z; Cai X; Wang M; Xu F; Zheng J; Xiao H
    Carcinogenesis; 2017 Apr; 38(4):455-464. PubMed ID: 28207072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A metabolite of nobiletin, 4'-demethylnobiletin and atorvastatin synergistically inhibits human colon cancer cell growth by inducing G0/G1 cell cycle arrest and apoptosis.
    Wu X; Song M; Qiu P; Li F; Wang M; Zheng J; Wang Q; Xu F; Xiao H
    Food Funct; 2018 Jan; 9(1):87-95. PubMed ID: 29063088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
    Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
    Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination Chemotherapy of Lung Cancer - Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid-Polymer Hybrid Nanoparticles.
    Wu R; Zhang Z; Wang B; Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
    Drug Des Devel Ther; 2020; 14():2249-2261. PubMed ID: 32606595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung Cancer Combination Treatment: Evaluation of the Synergistic Effect of Cisplatin Prodrug, Vinorelbine and Retinoic Acid When Co-Encapsulated in a Multi-Layered Nano-Platform.
    Liang Z; Li J; Zhu B
    Drug Des Devel Ther; 2020; 14():4519-4531. PubMed ID: 33149550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
    Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
    Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer.
    Yuan Z; Yuan Y; Han L; Qiu Y; Huang X; Gao F; Fan G; Zhang Y; Tang X; He X; Xu K; Yin P
    Int J Nanomedicine; 2018; 13():7533-7548. PubMed ID: 30532537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic actions of atorvastatin with gamma-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells.
    Yang Z; Xiao H; Jin H; Koo PT; Tsang DJ; Yang CS
    Int J Cancer; 2010 Feb; 126(4):852-63. PubMed ID: 19626588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
    Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
    Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer.
    Zhang X; He Z; Xiang L; Li L; Zhang H; Lin F; Cao H
    Drug Des Devel Ther; 2019; 13():1357-1372. PubMed ID: 31118572
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitamin E Succinate-Grafted-Chitosan Oligosaccharide/RGD-Conjugated TPGS Mixed Micelles Loaded with Paclitaxel for U87MG Tumor Therapy.
    Chen Y; Feng S; Liu W; Yuan Z; Yin P; Gao F
    Mol Pharm; 2017 Apr; 14(4):1190-1203. PubMed ID: 28212490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RGD peptide-decorated micelles assembled from polymer-paclitaxel conjugates towards gastric cancer therapy.
    Shi J; Liu S; Yu Y; He C; Tan L; Shen YM
    Colloids Surf B Biointerfaces; 2019 Aug; 180():58-67. PubMed ID: 31028965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RGD-Conjugated Resveratrol HSA Nanoparticles as a Novel Delivery System in Ovarian Cancer Therapy.
    Long Q; Zhu W; Guo L; Pu L
    Drug Des Devel Ther; 2020; 14():5747-5756. PubMed ID: 33408463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity.
    Yang F; Li A; Liu H; Zhang H
    Drug Des Devel Ther; 2018; 12():3321-3333. PubMed ID: 30323564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin inhibits proliferation and promotes apoptosis of colon cancer cells via COX-2/PGE2/β-Catenin Pathway.
    Cai S; Gao Z
    J BUON; 2021; 26(4):1219-1225. PubMed ID: 34564973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy.
    Li W; Liu D; Zhang H; Correia A; Mäkilä E; Salonen J; Hirvonen J; Santos HA
    Acta Biomater; 2017 Jan; 48():238-246. PubMed ID: 27815166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chondroitin sulfate-functionalized polymeric nanoparticles for colon cancer-targeted chemotherapy.
    Zu M; Ma L; Zhang X; Xie D; Kang Y; Xiao B
    Colloids Surf B Biointerfaces; 2019 May; 177():399-406. PubMed ID: 30785037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Gastric Cancer Peptide GX1-Modified Nano-Lipid Carriers Encapsulating Paclitaxel: Design and Evaluation of Anti-Tumor Activity.
    Jian Y; Zhao M; Cao J; Fan T; Bu W; Yang Y; Li W; Zhang W; Qiao Y; Wang J; Wen A
    Drug Des Devel Ther; 2020; 14():2355-2370. PubMed ID: 32606603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticles.
    Liu J; Cheng H; Han L; Qiang Z; Zhang X; Gao W; Zhao K; Song Y
    Drug Des Devel Ther; 2018; 12():3199-3209. PubMed ID: 30288024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.